PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-10.68%
Negative net income growth while CRK stands at 98.05%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-1.31%
Negative yoy D&A while CRK is 763.09%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-76.13%
Negative yoy deferred tax while CRK stands at 98.26%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-112.62%
Both reduce yoy usage, with CRK at -109.05%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-112.62%
Negative yoy usage while CRK is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
104.45%
Some yoy increase while CRK is negative at -100.12%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-10.38%
Both yoy CFO lines are negative, with CRK at -66.14%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
15.81%
CapEx growth well above CRK's 15.23%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-836.40%
We reduce yoy other investing while CRK is 100.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-7.91%
We reduce yoy invests while CRK stands at 81.39%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.